# Sodium Polystyrene Sulfonate

NDC: 62135-340
Generic name: Sodium Polystyrene Sulfonate
Labeler / Manufacturer: Chartwell RX, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL, RECTAL
Marketing started: 20160218

FDA application: ANDA206815

## Active ingredients

- SODIUM POLYSTYRENE SULFONATE: 4.1 meq/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62135-340"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62135-340
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e910a2f9-07ee-4e8f-95bd-f124e1306ff7